Catalyst Wire Dossier Catalyst Wire Dossier

allogenic umbilical cord blood and erythropoietin combination therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for allogenic umbilical cord blood and erythropoietin combination therapy, covering 2012-03-01 to 2012-03-01. Get the full timeline:

Most recent: Clinical Trial Update: Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy [NA]

See pricing